These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15346967)

  • 1. [Isolation of Chryseomonas luteola in a patient with combined trauma].
    Sivolodskiĭ EP; Suborova TN; Fedotova ON; Boiarintsev VV; Gavrilin SV; Lebedev VF; Suvorov VV; Pavlenko AI
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):117-8. PubMed ID: 15346967
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare infection caused by Chryseomonas luteola.
    Ghosh SK
    J Infect; 2000 Jul; 41(1):109-10. PubMed ID: 10942647
    [No Abstract]   [Full Text] [Related]  

  • 3. Leg ulcer due to Pseudomanas luteola in a patient with sickle cell disease.
    Tsakris A; Hassapopoulou H; Skoura L; Pournaras S; Douboyas J
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):141-3. PubMed ID: 11858911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of a Chrysemonas luteola strain isolated from a healthy carrier and investigation of pathogenicity, virulence and antibiotic resistance factors through in vitro and in vivo studies].
    Israil A; Balotescu C; Alexandru I
    Bacteriol Virusol Parazitol Epidemiol; 2004; 49(1-2):43-7. PubMed ID: 16752751
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nature and sensitivity of bacteria superinfecting plantar ulcers caused by leprosy at the Marchoux Institute, Bamako, Mali].
    Tiendrebeogo A; Coulibaly I; Sarr AM; Sow SO
    Acta Leprol; 1999; 11(4):153-9. PubMed ID: 10987046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas luteola cutaneous abscess and bacteraemia in a previously healthy man.
    Dalamaga M; Karmaniolas K; Chavelas C; Liatis S; Matekovits H; Migdalis I
    Scand J Infect Dis; 2004; 36(6-7):495-7. PubMed ID: 15307579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteremia caused by Pseudomonas luteola in pediatric patients.
    Bayhan GI; Senel S; Tanir G; Ozkan S
    Jpn J Infect Dis; 2015; 68(1):50-4. PubMed ID: 25420649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2).
    Rahav G; Simhon A; Mattan Y; Moses AE; Sacks T
    Medicine (Baltimore); 1995 Mar; 74(2):83-8. PubMed ID: 7891546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas maltophilia infections in man.
    Gilardi GL
    Am J Clin Pathol; 1969 Jan; 51(1):58-61. PubMed ID: 5766111
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.
    Wildermuth BE; Griffin CE; Rosenkrantz WS; Boord MJ
    J Am Anim Hosp Assoc; 2007; 43(6):337-41. PubMed ID: 17975216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp.
    Naesens R; Jansens H; Goossens H; Ieven M; Vlieghe E
    Int J Antimicrob Agents; 2010 May; 35(5):514-5. PubMed ID: 20188527
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudomonas cepacia in the West of Scotland.
    Henderson A; Byatt ME
    Health Bull (Edinb); 1974 May; 32(3):100-2. PubMed ID: 4418941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pseudomonas maltophilia infections].
    Pintér M; Kántor M
    Orv Hetil; 1974 Feb; 115(5):254-5. PubMed ID: 4839507
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pseudomonas maltophilia in cerebrospinal fluid samples. Isolation, identification and antibiograms of 4 strains].
    Mulinas L; Lorente S; Borras R; Ferrer A; Sanchis-Bayarri Vaillant V
    Rev Clin Esp; 1977 Jul 15-31; 146(1-2):31-4. PubMed ID: 897286
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
    Fodor E; Hajdú E; Nagy E
    Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monitoring of antibiotic resistance in Ps. aeruginosa and in Ps. maltophilia in the Ospedale di Pordenone].
    Chiaradia V; Santini GF
    G Ital Chemioter; 1988; 35(1-3):23-5. PubMed ID: 3151487
    [No Abstract]   [Full Text] [Related]  

  • 18. Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital.
    Chihab W; Alaoui AS; Amar M
    J Clin Microbiol; 2004 Apr; 42(4):1837-9. PubMed ID: 15071064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation and identification of a strain of Pseudomonas putrefaciens].
    Sanchis-Bayarri Vaillant V; Sanchis-Bayarri Lahoz V
    Rev Clin Esp; 1981 Apr; 161(2):119-20. PubMed ID: 7280316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.